Seven cellular loci with acceptor sites for retroviral integrations have been mapped for the presence of DNase I-hypersensitive sites in chromatin. Integrations in three of these loci, chicken c-erbB, rat c-myc, and a rat locus, dsi-1, had been selected for in retrovirus-induced tumors. Of the remaining four, two, designated dsi-3 and dsi-4, harbored acceptor sites for apparently unselected integrations of Moloney murine leukemia virus in a Moloney murine leukemia virus-induced thymoma, and two, designated C and F, harbored unselected acceptor sites for Moloney murine leukemia virus integrations in a rat fibroblast cell line. Each acceptor site mapped to within 500 base pairs of a DNase I-hypersensitive site. In the analyses of the unselected integrations, six hypersensitive sites were observed in 39 kilobases of DNA. The four acceptor sites in this DNA were localized between 0.05 and 0.43 kilobases of a hypersensitive site. The probability of this close association occurring by chance was calculated to be extremely low. Hypersensitive sites were mapped in cells representing the lineage in which integration had occurred as well as in an unrelated lineage. In six of the seven acceptor loci hypersensitive sites could not be detected in the unrelated lineage. Our results indicate that retroviruses preferentially integrate close to DNase I-hypersensitive sites and that many of these sites are expressed in some but not all cells.
A central feature of the retrovirus lifecycle is the ordered integration of the DNA form of the viral genome into the host genome. Integration is accomplished by recombination between viral long terminal repeat and host sequences. An early step in integration, endonucleolytic cleavage of long terminal repeat and host sequences, appears to be catalyzed by the product of the viral pol gene. This is evidenced by in vitro cleavage of the preintegration form of viral DNA near the junction of the long terminal repeats by purified reverse transcriptase (8) . Recombination between viral and host sequences occurs at a specific position within the long terminal repeat, generally 2 base pairs (bp) internal to the termini (14, 18, 26) . In contrast, host acceptor sites for integrations appear to be at least locally nonspecific, with analyses of host-virus junctions failing to reveal a consensus acceptor sequence (for review, see reference 32) . Host sequences are duplicated at the site of integration, with the number of duplicated bases being characteristic of the virus (6, 12, 18, 25) . The replication of chromosomal DNA appears to be a necessary requirement for integration, with proviruses undergoing insertion into newly synthesised DNA (33) .
Despite the apparent absence of sequence specificity for acceptor sites, chromatin structure may determine regional specificity of integration. DNase I and Si digestions of chromatin reveal short regions of DNA which are hypersensitive to digestion (for reviews, see references 19, 35) . DNase I-hypersensitive sites are thought to represent regions of chromatin which may be preferentially available for the entry of proteins that effect the replication, transcription, and rearrangement of DNA (19, 29, 40) . These regions may also be preferentially available for the integration of retroviral DNA. In bursal lymphomas, avian leukosis virus integrations map near each of the five major hypersensitive sites which are immediately upstream of the coding sequences for c-myc (23, 24) . The integration of a Moloney murine leuke-* Corresponding author.
mia virus (MoMLV) provirus in the alpha 1 collagen gene has also been mapped near a DNase I-hypersensitive site (4) . To determine whether the occurrence of retroviral integrations near DNase I-hypersensitive sites is a general phenomenon, we have mapped a series of acceptor sites for their proximity to DNase I-hypersensitive sites. Three of the loci were targets for insertions that had been selected for in retrovirus-induced tumors (20, 27 ; this paper), while four were targets for apparently unselected integrations (this paper; 13). Our results indicate that both selected and unselected integrations occur near DNase I-hypersensitive sites.
MATERIALS AND METHODS
Cell lines. The RCC2-1M cell lines was established from a MoMLV-induced rat thymoma. This cell line harbors more than 10 copies of MoMLV proviral DNA. None of the insertions were in the dsi-1, dsi-3, dsi-4, or c-myc locus. RCC2-1M cells were Two proviruses with flanking host sequences were molecularly cloned (13) from MoMLV-infected NRK cells. These clones were designated lambda 836 and lambda 21. The rat loci that harbor these two proviruses are called C and F, respectively. Lambda c-erbl, a clone containing the 5' end of the c-erbB gene of chickens (34) , was a kind gift of B. Vennstrom. The mouse myc clone S107 was provided by P. Leder (15) .
Molecularly (20) .
Sizing of fragments. Fragment sizes were routinely estimated from the positions of fragments relative to those of HindIII-digested lambda DNA. In some blots 32P-endlabeled 1-kilobase (kb) ladder fragments (Bethesda Research Laboratories) were used in sizing. Where possible, the positions of cellular fragments that had been determined from molecularly cloned DNAs were used in the construction of sizing curves. The sizes of fragments used to position hypersensitive sites are averages of independent analyses of different DNase I-treated DNAs. The sizing of these fragments, which are typically represented by broad and fuzzy bands, was done by measuring to a point about one-third of the way from the bottom of the band. Independent sizings were always within 10% of each other (a difference which would represent a 1-to 2-mm error in measurement on an autoradiograph of a typical Southern blot). Thus the position of a hypersensitive site represented by a 10-kb fragment is accurate to within ±500 bp, whereas the position of a hypersensitive site represented by a 1-kb fragment is accurate to within +50 bp. The positioning of proviral insertions was facilitated by the sizing of a series of junction fragments with defined ends in proviral sequences. The positions of one insertion each in rat c-myc and dsi-1 as well as the positions of each of the unselected insertions were determined with molecularly cloned DNA. We consider the positions of these insertions to be accurate to within 100 to 200 bp. Positioning of hypersensitive sites and integration sites was carried out independently so as not to bias the determinations.
Statistical analysis. Statistical analysis of the data in Table  1 was performed by Michael Sutherland, University of Massachusetts, Amherst. For each of the four unselected integrations, it was assumed that the positions of proviral integration and DNase I-hypersensitive sites were uniformly distributed over the region of DNA analyzed. Given that assumption, it was then possible to calculate the probability that the distance between these sites would be less than or equal to what was observed (37) . Having computed each of these four probabilites, the probability of the aggregate data being due to chance was the product of the four. The sensitivity of this calculation to errors in the measurement of DNA fragment size was determined by increasing the distance between the integration and hypersensitive sites and repeating the calculation. virus into the c-erbB region of the gene for the epidermal growth factor receptor (7, 17, 21, 31) cause erythroblastosis in line 151 chickens (11, 20, 22) . These insertions occur in a <1.5-kb region immediately upstream of sequences encoding the transmembrane domain of the receptor (20, 22) . DNase I-hypersensitive sites were mapped in this region in a line of erythroblasts (HD3) transformed by AEV-R. This cell line contained two normal alleles of c-erbB, c-erbB' and c-erbB" (11, 20) .
Hypersensitive sites were identifed by hybridizing Southern blots of SacI-digested DNAs with a probe for the 5' ends of the fragments that are acceptors for erythroblastosisinducing insertions (Fig. 1D ). This probe, erb-SR, detects chromosomal, but not viral, erbB sequences. Southern blots of HD3 chromatin that had not been digested with DNase I displayed only the 7.3-and 8.3-kb SacI fragments of c-erbB' and c-erbB", respectively, while those of chromatin that had been digested with increasing concentrations of DNase I revealed decreasing amounts of the 7.3-and 8.3-kb fragments and increasing amounts of a prominent 5.5-kb and a less prominent 4.5-kb fragment (Fig. 1A) . Based on the sizes of these two novel fragments, candidate hypersensitive sites were positioned 5.5 (HS1) and 4.5 (HS2) kb from the 5' ends of the acceptor Sacl fragments in c-erbB' and c-erbB" (Fig.  1D ). Verification that both HS1 and HS2 occur in c-erbB" was obtained by analyzing bone marrow from chickens with AEV-R-induced erythroblastosis. These chickens were homozygous for c-erbB". Both HS1 and HS2 were detected in leukemic marrows (Fig. 1B) , with the less prominent HS2 being observed in some but not all marrows. Each of seven erythroblastosis-inducing avian leukosis virus insertions in c-erbB" (20) mapped within 500 nucleotides from HS2 (Fig.   1D ).
HS1 and HS2 were not detected in DNase I-treated chromatin of 10-day-old chicken embryos, bursa or thymus of young chicks, and erythrocytes from 14-day embryos or anemic adults (Fig. 1C and data not shown) . Thus, it appears that the c-erbB-hypersensitive sites are not expressed in all cells. The significance of these hypesensitive sites in different cell types is currently under investigation.
Thymoma-associated insertion in rat c-myc. From 10 to 20% of thymic lymphomas induced in rats in MoMLV have MoMLV integrations near the 5' end of the rat c-myc gene (27, 30) . The normal as well as target c-myc alleles from one of these thymomas were molecularly cloned and mapped for restriction endonuclease sites (Steffen and Nacar, in preparation). These analyses as well as Southern blot analyses of thymoma DNAs positioned four thymoma-associated insertions 5' to the coding sequences for c-myc.
Chromatin does not carry an insertion in c-myc. Southern blots of KpnI-digested DNAs were hybridized with a probe (I mumyc) for unique sequences towards the 3' end of c-myc (Fig.  2B) . DNA from chromatin that had not been digested with DNase I gave rise to a single 14.2-kb fragment, whereas DNA from chromatin digested with increasing concentrations of DNase I revealed additional 10.6-, 8.2-, and 6.8-kb fragments ( Fig. 2A) . The sizes of these additional fragments positioned three hypersensitive sites 5' to the coding sequences of c-myc. HS1, represented by the 6.8-kb fragment, mapped within the first intron; HS2, represented by the 8.2-kb fragment, mapped to immediately 5' of the noncoding exon; and HS3, represented by the 10.6-kb fragment, mapped in upstream sequences. The positions of these sites were confirmed by the analysis of EcoRI-digested DNAs (27) .
The thymoma-associated insertions in three tumors mapped approximately 50, 100, and 300 bp from HS2, while the insertion in a fourth mapped about 300 bp from HS3. The rat c-myc-hypersensitive sites were also present in chromatin from a line of fibroblasts established from a normal rat kidney (NRK cells).
Thymoma-associated insertion in rat dsi-l. Recently we have observed that 3 of 24 MoMLV-induced thymomas have insertions in a locus designated dsi-1 (unpublished data). The restriction map and the location of highly repeated sequences in dsi-1 were deduced from molecularly cloned fragments which contained the insertion in dsi-1 as well as flanking 5' (lambda-5'dsl) and 3' (lambda-3'dsl) sequences. The positions of three apparently complete proviruses in dsi-1 were determined from the sizes of diagnostic restriction enzyme fragments in the molecularly cloned DNA as well as in Southern blots of tumor DNAs. DNase I-digested chromatin from the T-cell line RCC2-1M was analyzed for hypersensitive sites in dsi-1 by hybridizing Southern blots of EcoRI-plus HindIII-digested DNA with a probe for unique sequences (dsl-SR) at the 3' end of the fragment that was the acceptor for the three insertions (Fig. 3D) . RCC2-1M cells do not have a proviral insertion in dsi-1. A cluster of four prominent hypersensitive sites was observed (Fig. 3A) . The three lymphoma-associated insertions mapped within 300 bp of two of the hypersensitive sites in this cluster (Fig. 3D) . Hypersensitive sites further downstream of the lymphomaassociated insertions were mapped by using Southern blots of BglII-digested DNAs. These experiments revealed two hypersensitive sites about 4 kb downstream of the cluster in which proviral insertions had occurred (Fig. 3B) . Interestingly, DNase I digestion of the chromatin of NRK cells did not reveal hypersensitive sites in the EcoRI to HindIII fragment (Fig. 3C) , indicating that the hypersensitive sites near this insertion are not expressed in all cells.
Origin of unselected insertions. To determine whether unselected insertions also occur near DNase I-hypersensitive sites, sequences flanking two apparently unselected insertions in a MoMLV-induced thymoma as well as sequences flanking two unselected insertions in a MoMLVinfected NRK cell were mapped for their proximity to DNase I-hypersensitive sites. The two loci with apparently unselected proviruses in the MoMLV-induced thymoma are designated dsi-3 and dsi-4. There are two lines of evidence that suggest that the insertions in dsi-3 and dsi-4 were unselected. The first was obtained by testing for insertions in these loci in 24 MoMLV-induced thymomas. Unlike dsi-1, which had undergone insertions in two additional tumors, none of these 24 thymomas revealed an insertion in dsi-3 or dsi-4. Second, the insertions in dsi-3 and dsi-4 were cloned from a tumor RT10-2, which contained selected integrations in the proto-oncogene c-myc and in dsi- insertions in tumor RT10-2 was tumor inducing is highly unlikely. However, even if one of these two loci later turned out to be selected, this would not negate the significance of our results (see section on statistical analysis below). The loci which harbor the unselected insertions in NRK cells are designated C and F (13) . These insertions were molecularly cloned from a line of NRK cells (designated NRK-5) whose founder was cloned immediately following infection with MoMLV at a multiplicity of infection of -1 (28) . Since MoMLV infections do not alter the plating efficiency or the phenotype of NRK cells, and since, in particular, the growth properties of NRK-5 cells are similar to NRK cells, it is highly unlikely that insertions in C and F represent a growth-altering mutation in a proto-oncogene. The provirus at C is not expressed in NRK-5 cells, whereas the provirus at F presumably is expressed (13) .
Molecular clones of DNA flanking each of these insertions were mapped for the presence of restriction endonuclease sites and repeated DNA sequences. Appropriate restriction endonuclease sites and unique sequence probes were then used to demonstrate that the insertions were not associated with discernible rearrangements in host sequences.
Unselected insertions map near DNase I-hypersensitive sites. Cells representing the lineages in which the unselected insertions had occurred were analyzed for DNase Ihypersensitive sites near the sites of insertion. The RCC2-1M line of T cells was used to represent the T cell in which the insertions in the thymoma RT10-2 had occurred since the subclass of T cells in the thymus that gave rise to the thymoma is not known. RCC2-1M cells do not contain an insertion in dsi-3, dsi-4, C, or F. NRK cells were used to represent the lineage in which the insertions in an NRK cell had occurred.
A single hypersensitive site was observed in dsi-3 in the T-cell line RCC2-1M. This site was revealed by hybridizing Southern blots of BglII-digested DNA with probe ds3-XR for unique sequences towards the 3' end of the 12.8-kb acceptor BglII fragment (Fig. 4C) . Blots of DNase I-digested DNA revealed the 12.8-kb acceptor fragment as well as a novel 7.5-kb fragment (Fig. 4A ) which positioned a hypersensitive site approximately 150 bp from the insertion (Fig. 4C ). This hypersensitive site was detected in blots of two independent preparations of DNase I-digested DNA. DNase I-treated chromatin from NRK cells did not reveal the presence of this or other hypersensitive sites in dsi-3 (Fig. 4B) . The position of this hypersensitive site was confirmed by using an EcoRI digestion. Analysis of dsi-4 showed the presence of two distinct hypersensitive sites in DNase I-digested chromatin from the T-cell line RCC2-1M (Fig. 5A and C) . The provirus in dsi-4 in the tumor RT1O-2 had integrated approximately 400 bp away from the hypersensitive site represented by the novel 3.4-kb fragment (Fig. 5A and C) . The sizing of the fragment that positioned this site ranged from 3.4 to 3.6 kb in independent analyses of independent preparations of DNase I-treated DNA. Neither of the two hypersensitive sites in dsi-4 was detected in the chromatin of NRK cells (Fig. 5B) . Thus, hypersensitive sites in dsi-3 and dsi-4 are present in a line of T cells but not in fibroblasts. The same preparation of NRK cells revealed the presence of the hypersensitive sites in c-myc, as well as in loci C and F (see below), indicating that the failure to see the hypersensitive sites in dsi-3 and dsi-4 was not due to technical problems related to the preparation of chromatin from these cells.
Analyses for hypersensitive sites in rat locus C (an acceptor for an unselected integration in NRK cells) revealed a single hypersensitive site in the chromatin of NRK cells (Fig.  6A) . This hypersensitive site mapped -50 bp from the integration in C (Fig. 6C) . Two independent analyses of independent preparations of DNase I-treated chromatin po- sitioned this hypersensitive site within a 250-bp range. Once again, this hypersensitive site could not be detected in the chromatin of RCC2-1M cells (Fig. 6B) .
The restriction map of locus F is shown in Fig. 7C . Southern blots of SacI-digested chromatin from NRK cells revealed novel 2.2-and 1.45-kb fragments in DNase I-A digested DNA (Fig. 6A) Fig. 4 to 7. 1M T cells did not reveal the presence of either of these two hypersensitive sites (Fig. 7B) . Thus, the hypersensitive sites that map close to two unselected integrations in NRK cells were absent from DNase I-treated DNA of RCC2-1M cells, although these cells contained hypersensitive sites at c-myc, dsi-1, dsi-3, and dsi-4.
Statistical analysis of the distribution of acceptor and hypersensitive sites in regions with unselected insertions. Table 1 summarizes the positions of unselected proviral integrations and DNase I-hypersensitive sites. These data were subjected to several statistical analyses which made no assumptions about the frequency distribution of DNase I-hypersensitive sites in the rat genome, but rather asked whether the positions of DNase I-hypersensitive sites and proviral integration sites within the 6.4-to 12.8-kb DNA analyzed for each locus were likely to have occurred by chance. Initially we asked what portion of the total DNA analyzed in Table 1 was near a hypersensitive site and whether four insertions would have occurred in this portion of the total DNA by chance. The calculation indicated that the probability that each of the four unselected proviruses would have inserted within 500 bp of a hypersensitive site was 9 x 10-4. Even if one of these four insertions turned out to be selected, the probability of the remaining three occurring within 500 bp of a hypersensitive site was 5 x 10-3.
The data in Table 1 were also analyzed by using the null hypothesis that DNase I-hypersensitive sites and proviral integration sites are uniformly distributed along the region of DNA analyzed and therefore are not associated. The probability of the observed distribution occurring was calculated to be 2 x 10-6. To determine how sensitive this calculation was to inaccuracies in mapping, each of the integration sites was then moved 500 bp farther away from the closest hypersensitive site and the total length of the fragments analyzed was decreased by 10%. The probability was recalculated and found to be 5 x 10-4. Finally, the calculation was repeated for only three of the insertions being unselected and using the worst-case assumptions for sizing errors. The association between the remaining three integrations and the positions of DNase I-hypersensitive sites was still statistically significant (P = 6 x 10-3).
DISCUSSION
Our results show the presence of consistently observed DNase I-hypersensitive sites near acceptor sites for proviral integrations in seven regions of chromosomal DNA. Three of these regions, c-erbB, c-myc, and dsi-1, were targets for multiple tumor-inducing insertions. In these cases, the close proximity of hypersensitive and acceptor sites could be required for tumor induction. However, the demonstration that the four unselected insertions also occur near DNase Interestingly, the cell lineages that were unrelated to the infected cell tended not to display hypersensitive sites near sites of insertion. A preparation of DNase I-treated chromatin from NRK cells displayed hypersensitive sites in loci C and F (targets for insertions in NRK cells) but did not display such sites in loci dsi-1, dsi-3, or dsi-4 (targets for insertion in a rat thymoma). Similarly, preparations of DNase I-treated chromatin from the cells cultured from a thymoma contained hypersensitive sites in dsi-1, dsi-3, and dsi-4 but not in C and F. The hypersensitive sites in the chicken c-erbB gene were detected only in AEV-R-transformed erythroblasts. These sites were not detected in the DNase I-treated chromatin of 10-day embryos, thymus, or bursa or in erythrocytes from 14-day embryos or anemic adults which displayed clear hypersensitive sites in c-myc. Of the seven regions analyzed, only one, c-myc, displayed hypersensitive sites in lineages that were both related and unrelated to the target cell. The frequent occurrence of insertions near hypersensitive sites expressed in some but not all cells is provocative in that it suggests that tissue-specific hypersensitive sites may be particularly available for retroviral integrations.
One could argue that the sites observed near insertions were not present in the target cell but occurred by chance in the cells used to represent the target cell. We think this unlikely because hypersensitive sites are not sufficiently frequent in cellular DNA for chance to account for their consistent presence near sites of insertion in chromatin from cells representing the target cell. This is evidenced by six of the seven tested regions not displaying hypersensitive sites in cells unrelated to the target cell.
Role of DNase I-hypersensitive sites in integration. The finding that regions of chromatin near DNase I-hypersensitive sites may be preferred sites for retroviral integrations is not surprising. These regions are identified by virture of their high availability for digestion by endonucleases, a reaction which represents an early step in the recombination of viral and host sequences. Thus the occurrence of integrations near DNase I-hypersensitive sites is consistent with what is known about the enzymology of integration and the availability of chromosomal DNA for such enzymatic reactions.
DNase I-hypersensitive sites as preferred sites of integration for all retrotransposons. Although acceptor sites for other elements that undergo reverse transcription and ordered integration into host DNA have not been analyzed for their proximity to DNase I-hypersensitive sites, the positions of selected as well as unselected insertions of these elements in known genes are consistent with insertions preferentially occurring close to DNase I-hypersensitive sites. For exam-ple, hypersensitive sites frequently occur at the 5' ends of genes or at sequences involved in chromosomal rearrangements. Insertions of intracistemal type A particles have been mapped near the 5' end of the proto-oncogene c-mos (5) and near the site in the mouse kappe gene which undergoes rearrangements (16) . Also, insertions of the Ty elements of yeasts occur at the 5' ends of the LYS2, ADH2, CYC7, CAR], and HIS3 genes and near the 5' ends of several tRNA genes (9) . Most of the above insertions were selected for the alteration of a phenotype. In certain cases, the selection might have enriched for insertions at the 5' ends of genes by requiring that the insertion not disrupt a coding sequence. However, Ty insertions into LYS2 and HIS4 were selected for the inactivation of a gene product which should not have discriminated against recombinations throughout the body of the gene. In conclusion, we suggest that all retrotransposons will preferentially integrate near DNase I-hypersensitive sites.
